No Data
NKFPharma's Unit Gets Regulatory Nod to Market Azacitidine for Injection
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH): Subsidiary's injection azacitidine obtained pharmaceutical registration certificate.
On July 19th, Gelonhui reported that Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (referred to as "Jinjin Pharmaceutical" below), a subsidiary of the company, recently received a notice from the National Medical Products Administration (referred to as "NMPA") regarding the approval and issuance of the registration certificate for the injection of Azacitidine (specification: 100mg) (Drug Approval Number: National Drug Certificate H20244451). Azacitidine for injection is used to treat the following adult patients: intermediate-2 and high-risk myelodysplastic syndrome (MDS) in the International Prognostic Scoring System (IPSS); chronic granulocytic-monocytic leukemia.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) will distribute a cash dividend for the year 2023 on July 8th, with a dividend of 0.1 yuan per share.
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) announced that the company will distribute cash dividends for the 2023 fiscal year on July 8, 2024, at a rate of 0.1 yuan per share (tax included). The ex-right (ex-dividend) date for this equity distribution is July 5, 2024, and the record date is July 8, 2024.
Nanjing King-Friend Biochemical Pharma Registers Regadenoson Injection in China; Shares Up 3%
Nanjing King-Friend Biochemical PharmaceuticalLtd (SHSE:603707) Investors Are Sitting on a Loss of 50% If They Invested Three Years Ago
Nanjing King-Friend Biochemical Pharmaceutical (603707.SH) obtained the registration certificate for Rijiano injection.
Nanjing King-friend Biochemical Pharmaceutical (603707.SH) announced that the company recently received the National Medical Products Administration ("NMPA")...
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.'s (SHSE:603707) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?No Data
